Cargando…

VRK1 Is a Synthetic–Lethal Target in VRK2-Deficient Glioblastoma

Synthetic lethality is a genetic interaction that results in cell death when two genetic deficiencies co-occur but not when either deficiency occurs alone, which can be co-opted for cancer therapeutics. Pairs of paralog genes are among the most straightforward potential synthetic–lethal interactions...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shields, Julie A., Meier, Samuel R., Bandi, Madhavi, Mulkearns-Hubert, Erin E., Hajdari, Nicole, Ferdinez, Maria Dam, Engel, Justin L., Silver, Daniel J., Shen, Binzhang, Zhang, Wenhai, Hubert, Christopher G., Mitchell, Kelly, Shakya, Sajina, Zhao, Shan-Chuan, Bejnood, Alborz, Zhang, Minjie, Tjin Tham Sjin, Robert, Wilker, Erik, Lathia, Justin D., Andersen, Jannik N., Chen, Yingnan, Li, Fang, Weber, Barbara, Huang, Alan, Emmanuel, Natasha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2022
Materias:	Tumor Biology and Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627132/ https://www.ncbi.nlm.nih.gov/pubmed/36069976 http://dx.doi.org/10.1158/0008-5472.CAN-21-4443

Ejemplares similares

Differential Inhibitor Sensitivity between Human Kinases VRK1 and VRK2
por: Vázquez-Cedeira, Marta, et al.
Publicado: (2011)

VRK1 as a synthetic lethal target in VRK2 promoter–methylated cancers of the nervous system
por: So, Jonathan, et al.
Publicado: (2022)

Comparative Interactomes of VRK1 and VRK3 with Their Distinct Roles in the Cell Cycle of Liver Cancer
por: Lee, Namgyu, et al.
Publicado: (2017)

Proteomics Identification of Nuclear Ran GTPase as an Inhibitor of Human VRK1 and VRK2 (Vaccinia-related Kinase) Activities
por: Sanz-García, Marta, et al.
Publicado: (2008)

Autonomous pick-and-place using the dVRK
por: D’Ettorre, Claudia, et al.
Publicado: (2021)

VRK1 Kinase Activity Modulating Histone H4K16 Acetylation Inhibited by SIRT2 and VRK-IN-1
por: Monte-Serrano, Eva, et al.
Publicado: (2023)

The C/H3 Domain of p300 Is Required to Protect VRK1 and VRK2 from their Downregulation Induced by p53
por: Valbuena, Alberto, et al.
Publicado: (2008)

Functional characterization of lysosomal interaction of Akt with VRK2
por: Hirata, Noriyuki, et al.
Publicado: (2018)

Vrk1 partial Knockdown in Mice Results in Reduced Brain Weight and Mild Motor Dysfunction, and Indicates Neuronal VRK1 Target Pathways
por: Vinograd-Byk, Hadar, et al.
Publicado: (2018)

VRK1 functional insufficiency due to alterations in protein stability or kinase activity of human VRK1 pathogenic variants implicated in neuromotor syndromes
por: Martín-Doncel, Elena, et al.
Publicado: (2019)

Dissecting the roles of Haspin and VRK1 in histone H3 phosphorylation during mitosis
por: Cartwright, Tyrell N., et al.
Publicado: (2022)

VRK-1 extends life span by activation of AMPK via phosphorylation
por: Park, Sangsoon, et al.
Publicado: (2020)

Data on the identification of VRK2 as a mediator of PD-1 function
por: Peled, Michael, et al.
Publicado: (2021)

Effects of VRK2 (rs2312147) on White Matter Connectivity in Patients with Schizophrenia
por: Sohn, Hoyoung, et al.
Publicado: (2014)

Novel motor phenotypes in patients with VRK1 mutations without pontocerebellar hypoplasia
por: Stoll, Marion, et al.
Publicado: (2016)

Adult-Onset Spinal Muscular Atrophy due to Mutations in the VRK1 Gene
por: Sung, Angela, et al.
Publicado: (2021)

VRK1 Depletion Facilitates the Synthetic Lethality of Temozolomide and Olaparib in Glioblastoma Cells
por: Navarro-Carrasco, Elena, et al.
Publicado: (2021)

Downregulation of VRK1 by p53 in Response to DNA Damage Is Mediated by the Autophagic Pathway
por: Valbuena, Alberto, et al.
Publicado: (2011)

Oncogenic Sox2 regulates and cooperates with VRK1 in cell cycle progression and differentiation
por: Moura, David S., et al.
Publicado: (2016)

A novel VRK1 mutation associated with recessive distal hereditary motor neuropathy
por: Feng, Shu‐Yan, et al.
Publicado: (2018)

Novel alternatively-spliced exons of the VRK2 gene in mouse brain and microglial cells
por: Almarzooq, Salsabil, et al.
Publicado: (2020)

Novel VRK1 Mutations in a Patient with Childhood-onset Motor Neuron Disease
por: Yamaura, Genpei, et al.
Publicado: (2019)

VRK2 identifies a subgroup of primary high-grade astrocytomas with a better prognosis
por: Rodríguez-Hernández, Irene, et al.
Publicado: (2013)

Implication of the VRK1 chromatin kinase in the signaling responses to DNA damage: a therapeutic target?
por: Campillo-Marcos, Ignacio, et al.
Publicado: (2018)

VRK2A is an A-type lamin–dependent nuclear envelope kinase that phosphorylates BAF
por: Birendra KC,, et al.
Publicado: (2017)

Identification of VRK1 as a New Neuroblastoma Tumor Progression Marker Regulating Cell Proliferation
por: Colmenero-Repiso, Ana, et al.
Publicado: (2020)

HNRNP A1 Promotes Lung Cancer Cell Proliferation by Modulating VRK1 Translation
por: Ryu, Hye Guk, et al.
Publicado: (2021)

VRK1 Predicts Poor Prognosis and Promotes Bladder Cancer Growth and Metastasis In Vitro and In Vivo
por: Wu, Jiacheng, et al.
Publicado: (2022)

Multivalent DNA and nucleosome acidic patch interactions specify VRK1 mitotic localization and activity
por: Budziszewski, Gabrielle R, et al.
Publicado: (2022)

The pattern of histone H3 epigenetic posttranslational modifications is regulated by the VRK1 chromatin kinase
por: Monte-Serrano, Eva, et al.
Publicado: (2023)

Downregulation of VRK1 Inhibits Progression of Lung Squamous Cell Carcinoma through DNA Damage
por: Du, Ning, et al.
Publicado: (2023)

Modulation of Interleukin-1 Transcriptional Response by the Interaction between VRK2 and the JIP1 Scaffold Protein
por: Blanco, Sandra, et al.
Publicado: (2008)

Human VRK2 modulates apoptosis by interaction with Bcl-xL and regulation of BAX gene expression
por: Monsalve, D M, et al.
Publicado: (2013)

VRK1 regulates Cajal body dynamics and protects coilin from proteasomal degradation in cell cycle
por: Cantarero, Lara, et al.
Publicado: (2015)

Motor neuron diseases caused by a novel VRK1 variant – A genotype/phenotype study
por: Sedghi, Maryam, et al.
Publicado: (2019)

Dysregulation of Cellular VRK1, BAF, and Innate Immune Signaling by the Vaccinia Virus B12 Pseudokinase
por: Linville, Alexandria C., et al.
Publicado: (2022)

Connexins in Cancer: Jekyll or Hyde?
por: Mulkearns-Hubert, Erin E., et al.
Publicado: (2020)

Human VRK1 Is an Early Response Gene and Its Loss Causes a Block in Cell Cycle Progression
por: Valbuena, Alberto, et al.
Publicado: (2008)

HnRNP A1 phosphorylated by VRK1 stimulates telomerase and its binding to telomeric DNA sequence
por: Choi, Yoon Ha, et al.
Publicado: (2012)

Depletion of the protein kinase VRK1 disrupts nuclear envelope morphology and leads to BAF retention on mitotic chromosomes
por: Molitor, Tyler P., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_5veaq419b51aegg62ask06rp3i